MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on September 1, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on September 1, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on September 1, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on September 1, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on September 1, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on September 1, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Fibrinolytic capacity in hemodialysis patients treated with recombinant human erythropoietin.
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
II study.
Therapy with human recombinant erythropoietin in patients with myelodysplastic syndromes.
Hepatic computed tomography for monitoring the iron status of haemodialysis patients with haemosiderosis treated with recombinant human erythropoietin.
Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.
Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.
Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients.
Treating renal anaemia with recombinant human erythropoietin.
Erythropoietin for zidovudine-induced anemia.
Recombinant human erythropoietin and the treatment of anemia in patients with AIDS or advanced ARC not receiving ZDV.
A reduced dose of zidovudine in patients with AIDS.
Evaluation of hemodialysis patients treated with erythropoietin.
Excessive growth of eyelashes in a patient with AIDS being treated with zidovudine.
Dialysis patients with the metabolic syndrome need less recombinant human erythropoietin for similar hemoglobin levels.
Intrathecal zidovudine for AIDS dementia.
Recombinant human erythropoietin for autologous blood donation.
Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism.
Vitamin B12 injections in patients treated with zidovudine.
Intrathecal zidovudine for AIDS dementia.
Treatment of renal anemia with recombinant human erythropoietin.
The treatment of anemia with low-dose recombinant human erythropoietin.
Dilated cardiomyopathy in a zidovudine-treated AIDS patient.
AIDS patients with zidovudine.
Recombinant human erythropoietin for patients with AIDS treated with zidovudine.
Bone marrow suppression and anemia are frequent side effects of treatment of the acquired immunodeficiency syndrome (AIDS) with zidovudine (formerly a...
1MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Fibrinolytic capacity in hemodialysis patients treated with recombinant human erythropoietin.
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
II study.
Therapy with human recombinant erythropoietin in patients with myelodysplastic syndromes.
Hepatic computed tomography for monitoring the iron status of haemodialysis patients with haemosiderosis treated with recombinant human erythropoietin.
Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.
Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.
Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients.
Treating renal anaemia with recombinant human erythropoietin.
Erythropoietin for zidovudine-induced anemia.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms